KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Gsk (GSK) Income from Continuing Operations (2016 - 2026)

Gsk has reported Income from Continuing Operations over the past 18 years, most recently at 2890494488.63 for Q1 2026.

  • For Q1 2026, Income from Continuing Operations rose 8.87% year-over-year to 2890494488.63; the TTM value through Mar 2026 reached 9985530018.63, up 20.55%, while the annual FY2025 figure was 8365415222.16, 120.86% up from the prior year.
  • Income from Continuing Operations for Q1 2026 was 2890494488.63 at Gsk, up from 1263657888.54 in the prior quarter.
  • Over five years, Income from Continuing Operations peaked at 4833045441.69 in Q4 2023 and troughed at 83155210.66 in Q3 2024.
  • A 5-year average of 2384209644.09 and a median of 2486458585.09 in 2023 define the central range for Income from Continuing Operations.
  • Biggest five-year swings in Income from Continuing Operations: crashed 96.33% in 2024 and later soared 3885.36% in 2025.
  • Year by year, Income from Continuing Operations stood at 3507055680.2 in 2022, then skyrocketed by 37.81% to 4833045441.69 in 2023, then fell by 24.31% to 3657980242.27 in 2024, then plummeted by 65.45% to 1263657888.54 in 2025, then surged by 128.74% to 2890494488.63 in 2026.
  • Business Quant data shows Income from Continuing Operations for GSK at 2890494488.63 in Q1 2026, 1263657888.54 in Q4 2025, and 3314033434.67 in Q3 2025.